Clinical effect of early loading of eicosepentaenoic acid after percutaneous coronary intervention in patients with acute coronary syndrome: a prospective, open-labeled, randomized controlled clinical trial

Clinical effect of early loading of eicosepentaenoic acid after percutaneous coronary intervention in patients with acute coronary syndrome: a prospective, open-labeled, randomized controlled clinical trial - Clinical effect of early loading of eicosepentaenoic acid after percutaneous coronary intervention in patients with acute coronary syndrome: a prospective, open-labeled, randomized controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016723

Enrollment

200

Registered

2015-04-01

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

Patients receive standard medication containing 2 mg/day of pitavastatin as the control group. Patients receive 1800 mg/day of eicosapentaenoic acid in addition to standard medication containing 2 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute coronary syndrome patients treated with successful percutaneous coronary intervention within 24 hours

Exclusion criteria

Exclusion criteria: cardiogenic shock, severe renal insufficiency requiring dialysis or continuous hemofiltration, cardiopulumonary arrest, emergency coronary artery bypass and failure of percutaneous coronary intervention.

Design outcomes

Primary

Measure	Time frame
cardiovascular death, non-fatal myocardial infarction, stroke, and intervention for de novo coronary lesions.	—

Secondary

Measure	Time frame
Heart failure hospitalization	—

Countries

Japan

Contacts

Public ContactMasayuki Doi

Kagawa Prefectural Central Hopital Cardiology

mdoimd@gmail.com087-811-3333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026